Nutex Health Inc. (NUTX) Releases Q1 2026 Earnings: Revenue Miss, Strong EPS Beat Amid Margin Contraction

Nutex Health Inc. (NUTX) reported first-quarter 2026 results with mixed margin trends and strong bottom-line improvement.

Key financials:

Total revenue of $216.5 million, up 2.2% year‑over‑year.

Gross profit of $91.7 million, down 31.8% year‑over‑year.

Operating profit of $81.3 million, up 18.0% year‑over‑year.

Net income attributable to common shareholders of $46.8 million, up 219.9% year‑over‑year.

Diluted earnings per share of $6.52, up 154.7% year‑over‑year.

Guidance and analyst comparisons:

Revenue missed the consensus estimate of $232.5 million, about 6.9% below expectations.

EPS of $6.52 exceeded the estimate of $4.98, roughly a 31% beat.

Balance sheet and cash flow highlights:

Cash and cash equivalents of $207.3 million, up 136.5% year‑over‑year.

Cash from operating activities of $70.4 million, up 38.1% year‑over‑year.

Capital expenditures of $1.4 million, rising sharply versus the prior year.

Cost of sales of $124.8 million, up 61.4% year‑over‑year.

Total liabilities of $515.3 million, up 5.8% year‑over‑year.

Takeaway: Nutex Health's top line showing modest growth while gross margins contracted materially, yet operating profitability and net income delivered strong improvement and cash balances grew substantially, leaving the company with a much stronger liquidity position despite the revenue miss versus estimates.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Nutex Health Inc. Insider Trading Activity

Nutex Health Inc. insiders have traded $NUTX stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $NUTX stock by insiders over the last 6 months:

JON CHRISTIAN BATES (Chief Financial Officer) purchased 750 shares for an estimated $102,532
WARREN HOSSEINION (President) purchased 252 shares for an estimated $23,706
FRANK E JAUMOT purchased 150 shares for an estimated $14,033
PAMELA W. MONTGOMERY (Chief Legal Officer-Healthcare) purchased 79 shares for an estimated $7,020
KELVIN SPEARS purchased 10 shares for an estimated $944

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

Nutex Health Inc. Hedge Fund Activity

We have seen 61 institutional investors add shares of Nutex Health Inc. stock to their portfolio, and 48 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

TOPLINE CAPITAL MANAGEMENT, LLC added 118,927 shares (+21.4%) to their portfolio in Q4 2025, for an estimated $19,577,762
MORGAN STANLEY removed 63,161 shares (-52.3%) from their portfolio in Q4 2025, for an estimated $10,397,563
PERTENTO PARTNERS LLP added 54,001 shares (+20.0%) to their portfolio in Q4 2025, for an estimated $8,889,644
VANGUARD GROUP INC added 43,789 shares (+20.4%) to their portfolio in Q4 2025, for an estimated $7,208,545
PACER ADVISORS, INC. removed 31,930 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,256,316
SG AMERICAS SECURITIES, LLC added 29,449 shares (+3232.6%) to their portfolio in Q1 2026, for an estimated $2,798,832
HUSSMAN STRATEGIC ADVISORS, INC. added 21,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,457,020

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.